Volume 30, Issue 2 (October 2023)
J Birjand Univ Med Sci. 2023, 30(2): 131-140 |
Back to browse issues page
Research code: IR.IAU.SHK.REC.1402.053
Ethics code: IR.IAU.SHK.REC.1402.053
Clinical trials code: لازم ندارد
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Davoodi M, Zia Jahromi N. Study of lncRNADSCR9 expression rate in colorectal cancer patients. Journals of Birjand University of Medical Sciences 2023; 30 (2) :131-140
URL: http://journal.bums.ac.ir/article-1-3294-en.html
URL: http://journal.bums.ac.ir/article-1-3294-en.html
1- Department of Biology, Sciences Faculty, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
2- Department of Biology, Sciences Faculty, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran ,Nooshazia.59@gmail.com
2- Department of Biology, Sciences Faculty, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran ,
Abstract: (953 Views)
Background and Aims: Studies have shown that lncRNA DSCR9 prevents cancer and inflammation and its expression leads to anti-tumor activity. Therefore, this study aimed to investigate the relationship between lncRNA DSCR9 expression and the risk of colon cancer.
Materials and Methods: Samples were taken from 20 tissues of patients with colorectal cancer and 20 healthy intestinal tissues of healthy individuals. Total RNA extraction was performed, followed by cDNA synthesis. Expression of lncRNA DSCR9 was investigated using real-time reverse transcription–polymerase chain reaction and primers designed using Beacon Designer software. The relative expression of lncRNA DSCR9 was calculated, and finally, the results were analyzed by GraphPad Prism software.
Results: The results showed that lncRNA DSCR9 expression increased in colorectal cancer compared to the control group as well as in tumors of metastatic and non-metastatic individuals. However, the relative expression of lncRNA DSCR9 in tumors of individuals with stages 1 and 2 and in tumors of with different sizes did not show a significant increase; nevertheless, the relative expression of lncRNA DSCR9 in tumors of grades 1 and 2 was statistically significant (P=0.0144). The specificity and sensitivity of lncRNA DSCR9 showed that as a marker (P=0.0001), it could isolate the patient population from the healthy one.
Conclusion: In the present study, there was a relative increase in the expression of lncRNA DSCR9 in patients with colorectal cancer compared to control, which possibly could be due to the activation of proteins involved in cancer and increased Wnt/beta-catenin signaling pathway and cause tumor cell growth and angiogenesis in cancer. Therefore, due to changes in the expression of the lncRNA DSCR9 gene in colorectal cancer, this gene may be used as a biomarker for the detection of tumors.
Materials and Methods: Samples were taken from 20 tissues of patients with colorectal cancer and 20 healthy intestinal tissues of healthy individuals. Total RNA extraction was performed, followed by cDNA synthesis. Expression of lncRNA DSCR9 was investigated using real-time reverse transcription–polymerase chain reaction and primers designed using Beacon Designer software. The relative expression of lncRNA DSCR9 was calculated, and finally, the results were analyzed by GraphPad Prism software.
Results: The results showed that lncRNA DSCR9 expression increased in colorectal cancer compared to the control group as well as in tumors of metastatic and non-metastatic individuals. However, the relative expression of lncRNA DSCR9 in tumors of individuals with stages 1 and 2 and in tumors of with different sizes did not show a significant increase; nevertheless, the relative expression of lncRNA DSCR9 in tumors of grades 1 and 2 was statistically significant (P=0.0144). The specificity and sensitivity of lncRNA DSCR9 showed that as a marker (P=0.0001), it could isolate the patient population from the healthy one.
Conclusion: In the present study, there was a relative increase in the expression of lncRNA DSCR9 in patients with colorectal cancer compared to control, which possibly could be due to the activation of proteins involved in cancer and increased Wnt/beta-catenin signaling pathway and cause tumor cell growth and angiogenesis in cancer. Therefore, due to changes in the expression of the lncRNA DSCR9 gene in colorectal cancer, this gene may be used as a biomarker for the detection of tumors.
*Corresponding Author: Noosha Zia Jahromi; Emails: Nooshazia.59@gmail.com
You can also search for this author in: PubMed ResearchGate Scopus Google Scholar Google Scholar Profile
Type of Study: Original Article |
Subject:
Biochemistry
Received: 2023/06/21 | Accepted: 2023/09/23 | ePublished ahead of print: 2023/10/1 | ePublished: 2023/10/7
Received: 2023/06/21 | Accepted: 2023/09/23 | ePublished ahead of print: 2023/10/1 | ePublished: 2023/10/7
References
1. Sadat Kia F, Nazemalhosseini-Mojarad E, Forouzesh F. A quantitative investigation of the Bid gene expression in biopsies from colorectal adenomas. Tehran Univ Med J. 2018; 76(2): 120-8. [Persian] URL: http://tumj.tums.ac.ir/article-1-8772-en.html.
2. Setareh S, Zahiri Esfahani M, Zare Bandamiri M, Raeesi A, Abbasi R. Using Data Mining for Survival Prediction in Patients with Colon Cancer. Iran J Epidemiol. 2018; 14(1): 19-29. [Persian] URL: http://irje.tums.ac.ir/article-1-5961-en.html.
3. Pourfarzi F, Yazdanbod A, Daneshvar R, Saberi SH. Evaluation of effective factors in incidence of colorectal cancer. J Ardabil Univ Med Sci. 2012; 12(5): 56-64. [Persian] URL: http://jarums.arums.ac.ir/article-1-99-en.html.
4. Han-Shiang C. Curative resection of colorectal adenocarcinoma: multivariate analysis of 5-year follow-up. World J Surg. 1999; 23(12): 1301-6. DOI: 10.1007/s002689900666. [DOI:10.1007/s002689900666] [PMID]
5. Nadeem MS, Kumar V, Al-Abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases.Semin Cancer Biol. 2020;64: 51-60. DOI: 10.1016/j.semcancer.2019.05.001 [DOI:10.1016/j.semcancer.2019.05.001] [PMID]
6. Dehghan H, Salari A. Evaluation and treatment of colorectal cancer in Shahid Rahnemoon and Afshar hospitals, Yazd-Iran. J Shaheed Sadoughi Univ Med Sci. 2007; 15(3): 20-5. URL: http://jssu.ssu.ac.ir/article-1-644-en.html
7. Chen X, Yan G-Y. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics. 2013; 29(20): 2617-24. DOI: 10.1093/bioinformatics/btt426 [DOI:10.1093/bioinformatics/btt426] [PMID]
8. Consortium IHGS. Initial sequencing and analysis of the human genome. Nature. 2001; 409(6822): 860. DOI: 10.1038/35057062 [DOI:10.1038/35057062] [PMID]
9. Carter G, Miladinovic B, Patel AA, Deland L, Mastorides S, Patel NA. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBAClin. 2015; 4: 102-7. DOI: 10.1016/j.bbacli.2015.09.001 [DOI:10.1016/j.bbacli.2015.09.001] [PMID] []
10. Yu B, Liu L, Sun H, Chen Y. Long noncoding RNA AK056155 involved in the development of Loeys-Dietz syndrome through AKT/PI3K signaling pathway. Int J Clin Exp Pathol. 2015; 8(9): 10768-75. PMID: 26617788
11. Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2012; 41(D1): D983-D6. DOI: 10.1093/nar/gks1099 [DOI:10.1093/nar/gks1099] [PMID] []
12. Guo Z-H, You Z-H, Wang Y-B, Yi H-C, Chen Z-H. A learning-based method for LncRNA-disease association identification combing similarity information and rotation forest. J IScience. 2019; 19: 786-95. DOI: 10.1016/j.isci.2019.08.030. [DOI:10.1016/j.isci.2019.08.030] [PMID] []
13. Minami T. Down Syndrome Expressed Protein; DSCR-1 Deters Cancer and Septic Inflammation. Genetics and Etiology of Down Syndrome. 2011: 121. DOI: 10.5772/20975 [DOI:10.5772/20975]
14. Chen M, Wang J, Luo Y, Huang K, Shi X, Liu Y, et al. Identify Down syndrome transcriptome associations using integrative analysis of microarray database and correlation-interaction network. Hum Genomics. 2018; 12(1): 1-12. DOI: 10.1186/s40246-018-0133-y [DOI:10.1186/s40246-018-0133-y] [PMID] []
15. Ferns R, Nastouli E, Garson J. Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard. J Virol Methods. 2012; 179(1): 189-94. DOI: 10.1016/j.jviromet.2011.11.001 [DOI:10.1016/j.jviromet.2011.11.001] [PMID]
16. Baek K-H, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. J Nature. 2009; 459(7250): 1126-30. DOI: https://www.nature.com/articles/nature08062 [DOI:10.1038/nature08062] [PMID] []
17. Cho S-H, Jeon J, Kim SI. Personalized medicine in breast cancer: a systematic review. J Breast Cancer. 2012; 15(3): 265-72. DOI: 10.4048/jbc.2012.15.3.265 [DOI:10.4048/jbc.2012.15.3.265] [PMID] []
18. Vitiello M, Tuccoli A, Poliseno L. Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol (Dordr). 2015; 38(1): 17-28. DOI: 10.1007/s13402-014-0180-x [DOI:10.1007/s13402-014-0180-x] [PMID]
19. Lv C, Liu D, Wei X. Down syndrome critical region 1 positively correlates with angiogenesis in hypopharyngeal cancer. Mol Med Rep. 2017; 15(1): 263-70. DOI: 10.3892/mmr.2016.5989 [DOI:10.3892/mmr.2016.5989] [PMID]
20. Seo DS, Chau GC, Baek K-H, Um SH. A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis. Mol Metab. 2019; 21: 82-9. DOI: 10.1016/j.molmet.2018.12.002 [DOI:10.1016/j.molmet.2018.12.002] [PMID] []
21. Zhuang H, Huang S, Zhou Z, Ma Z, Zhang Z, Zhang C, et al. A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer. Cancer Cell Int. 2020; 20(1): 1-10. DOI: 10.1186/s12935-020-01588-y [DOI:10.1186/s12935-020-01588-y] [PMID] []
22. Wu X, Liu J, Zhu C, Ma M, Chen X, Liu Y, et al. Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks. Med Sci Monit. 2020; 26: e927725-1-9. DOI: 10.12659/MSM.927725 [DOI:10.12659/MSM.927725]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Attribution-NoneCommercial CC BY-NC